Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches (The ABC Study)

NCT02270957 is registered in ClinicalTrials.gov with Oklahoma Medical Research Foundation as lead sponsor.

NCT NCT02270957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02270957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches (The ABC Study)
Lead sponsor
Oklahoma Medical Research Foundation
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2014
Completion date
December 31, 2021
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus